Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells
Authors:
Open Access
- 28 March 2017
- journal article
- research article
- Published by SAGE Publications in Tumor Biology
- Vol. 39 (3)
Abstract
Recurrence of breast cancer after radiotherapy may be partly explained by the presence of radioresistant cells. Thus, it would be desirable to develop an effective therapy against radioresistant cells. In this study, we demonstrated the intense antitumor activity of cytokine-induced killer cells against MCF-7 and radioresistant MCF-7 cells, as revealed by cytokine-induced killer–mediated cytotoxicity, tumor cell proliferation, and tumor invasion. Radioresistant MCF-7 cells were more susceptible to cytokine-induced killer cell killing. The stronger cytotoxicity of cytokine-induced killer cells against radioresistant MCF-7 cells was dependent on the expression of major histocompatibility complex class I polypeptide–related sequence A/B on radioresistant MCF-7 cells after exposure of cytokine-induced killer cells to sensitized targets. In addition, we demonstrated that cytokine-induced killer cell treatment sensitized breast cancer cells to chemotherapy via the downregulation of TK1, TYMS, and MDR1. These results indicate that cytokine-induced killer cell treatment in combination with radiotherapy and/or chemotherapy may induce synergistic antitumor activities and represent a novel strategy for breast cancer.Keywords
This publication has 32 references indexed in Scilit:
- Profiling Global Kinome Signatures of the Radioresistant MCF-7/C6 Breast Cancer Cells Using MRM-based Targeted ProteomicsJournal of Proteome Research, 2014
- Adoptive cellular immunotherapy for the treatment of patients with breast cancer: A meta-analysisCytotherapy, 2014
- Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trialThe Lancet, 2014
- Cytokine-induced killer cells promote antitumor immunityJournal of Translational Medicine, 2013
- Cytokine-induced killer cells co-cultured with complete tumor antigen-loaded dendritic cells, have enhanced selective cytotoxicity on carboplatin-resistant retinoblastoma cellsOncology Reports, 2013
- Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA BarriersJournal of Immunotherapy, 2012
- Interleukin-6 Inhibits Regulatory T Cells and Improves the Proliferation and Cytotoxic Activity of Cytokine-induced Killer CellsJournal of Immunotherapy, 2012
- Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumorsExpert Opinion on Biological Therapy, 2012
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Studies of ex Vivo Activated and Expanded CD8+ NK-T Cells in Humans and MiceJournal of Clinical Immunology, 2002